Classical Steroids in a New Fashion: Focus on Testosterone and Aldosterone

Author(s): Daniela Jezova*, Lucia Balagova, Magdalena Chmelova, Natasa Hlavacova

Journal Name: Current Protein & Peptide Science

Volume 20 , Issue 11 , 2019

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Several endocrine glands produce steroid hormones. Thanks to the work of chemists and biochemists, the main synthetic as well as metabolic pathways of steroid hormones were included in the textbooks more than 50 years ago and the classical endocrine gland functions were identified. Later on, evidence of steroid hormone effects beyond the classical endocrine gland function has been accumulating. Testosterone was shown to participate in the stress response and may influence coping with stressors. We have shown a decrease in testosterone concentrations in saliva in children undergoing a school exam compared to values on a non-exam school day. Testosterone has been associated with different cognitive functions in both adults and children. Circulating testosterone has been linked to negative symptoms of schizophrenia. Aldosterone is acting via mineralocorticoid receptors, which are thought to be fully occupied by glucocorticoids in the brain. Until now, an action of aldosterone in the brain has not been considered at all, because the enzyme 11-beta-hydroxysteroid dehydrogenase type 2, which would enable aldosterone to bind to receptors is absent in most of the brain areas. We have brought evidence that aldosterone can act in the brain and produce anxiogenic and depressogenic effects. To facilitate the translation of animal findings into clinical research, we have developed methodology for measurement of salivary aldosterone and obtained first data on a relationship between salivary aldosterone and trait anxiety. We have shown that salivary aldosterone concentrations reflect treatment outcome in patients with major depressive disorder.

Keywords: Androgens, mineralocorticoid, stress, cognition, children, psychiatric disorders.

Starka, L. Advances in endocrinology, 1st ed; MAXDORF: Praha, 2007. (In Czech)
Melmed, S.; Polonsky, K.S.; Larsen, R.L.; Kronenberg, H.M. Williams Textbook of Endocrinology, 13th ed; Elsevier Health Sciences, 2015.
Beato, M.; Klug, J. Steroid hormone receptors: An update. Hum. Reprod. Update, 2000, 6(3), 225-236.
Melmed, S.; Polonsky, K.S.; Larsen, P.R.; Kronenberg, H.M. Williams Textbook of Endocrinology, 13th ed; Elsevier: Philadelphia, 2016.
Fatranska, M.; Repcekova-Jezova, D.; Jurcovicova, J.; Vigas, M. LH and testosterone response to LH-RH in blind men. Horm. Metab. Res., 1978, 10(1), 82-83.
Jezova, D.; Komadel, L.; Mikulaj, L. Plasma testosterone response to repeated human chorionic gonadotropin administration is increased in trained athletes. Endocrinol. Exp., 1987, 21(2), 143-147.
Repcekova, D.; Mikulaj, L. Plasma testosterone response to HCG in normal men without and after administration of anabolic drug. Endokrinologie, 1977, 69(1), 115-118.
Repcekova, D.; Mikulaj, L. Plasma testosterone of rats subjected to immobilization stress and/or HCG administration. Horm. Res., 1977, 8(1), 51-57.
Taché, Y.; Ducharme, J.R.; Charpenet, G.; Haour, F.; Saez, J.; Collu, R. Effect of chronic intermittent immobilization stress on hypophyso-gonadal function of rats. Acta Endocrinol. (Copenh.), 1980, 93(2), 168-174.
Jezova, D.; Vigas, M. Testosterone response to exercise during blockade and stimulation of adrenergic receptors in man. Horm. Res., 1981, 15(3), 141-147.
Jezova-Repcekova, D.; Vigas, M.; Mikulaj, L.; Jurcovicova, J. Plasma testosterone during bicycle ergometer exercise without and after L-dopa pretreatment. Endocrinol. Exp., 1982, 16(1), 3-8.
Jezova, D.; Vigas, M.; Tatar, P.; Kvetnansky, R.; Nazar, K.; Kaciuba-Uścilko, H.; Kozlowski, S. Plasma testosterone and catecholamine responses to physical exercise of different intensities in men. Eur. J. Appl. Physiol. Occup. Physiol., 1985, 54(1), 62-66.
Daly, W.; Seegers, C.A.; Rubin, D.A.; Dobridge, J.D.; Hackney, A.C. Relationship between stress hormones and testosterone with prolonged endurance exercise. Eur. J. Appl. Physiol., 2005, 93(4), 375-380.
Afrisham, R.; Sadegh-Nejadi, S. SoliemaniFar, O.; Kooti, W.; Ashtary-Larky, D.; Alamiri, F.; Aberomand, M.; Najjar-Asl, S.; Khaneh-Keshi, A. Salivary testosterone levels under psychological stress and its relationship with rumination and five personality traits in medical students. Psychiatry Investig., 2016, 13(6), 637-643.
Kuusi, T.; Kostiainen, E.; Vartiainen, E.; Pitkänen, L.; Ehnholm, C.; Korhonen, H.J.; Nissinen, A.; Puska, P. Acute effects of marathon running on levels of serum lipoproteins and androgenic hormones in healthy males. Metabolism, 1984, 33(6), 527-531.
Tauler, P.; Martinez, S.; Moreno, C.; Martínez, P.; Aguilo, A. Changes in salivary hormones, immunoglobulin A, and C-reactive protein in response to ultra-endurance exercises. Appl. Physiol. Nutr. Metab., 2014, 39, 560-565.
Kapsdorfer, D.; Hlavacova, N.; Vondrova, D.; Argalasova, L.; Sevcikova, L.; Jezova, D. Neuroendocrine response to school load in prepubertal children: Focus on trait anxiety. Cell. Mol. Neurobiol., 2018, 38(1), 155-162.
Gerra, G.; Zaimovic, A.; Zambelli, U.; Timpano, M.; Reali, N.; Bernasconi, S.; Brambilla, F. Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiology, 2000, 42(2), 82-92.
Wegner, M.; Koedijker, J.M.; Budde, H. The effect of acute exercise and psychosocial stress on fine motor skills and testosterone concentration in the saliva of high school students. PLoS One, 2014, 9(3)e92953
Prastyo, D.B.; Deliana, M.; Dimyati, Y.; Arto, K.S. The effect of psychological stress on salivary testosterone in puberty children. Open Access Maced. J. Med. Sci., 2018, 6(9), 1611-1616.
Crewther, B.T.; Obmiński, Z.; Orysiak, J.; Al-Dujaili, E.A.S. The utility of salivary testosterone and cortisol concentration measures for assessing the stress responses of junior athletes during a sporting competition. J. Clin. Lab. Anal., 2018, 32(1), [Epub 2017 Mar 13]. DOI: 10.1002/jcla.22197.,
Davis, S.R.; Wahlin-Jacobsen, S. Testosterone in women--the clinical significance. Lancet Diabetes Endocrinol., 2015, 3(12), 980-992.
Drake, E.B.; Henderson, V.W.; Stanczyk, F.Z.; McCleary, C.A.; Brown, W.S.; Smith, C.A.; Rizzo, A.A.; Murdock, G.A.; Buckwalter, J.G. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology, 2000, 54(3), 599-603.
Wolf, O.T.; Kirschbaum, C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm. Behav., 2002, 41(3), 259-266.
Kocoska-Maras, L.; Rådestad, A.F.; Carlström, K.; Bäckström, T.; von Schoultz, B.; Hirschberg, A.L. Cognitive function in association with sex hormones in postmenopausal women. Gynecol. Endocrinol., 2013, 29(1), 59-62.
Cherrier, M.M.; Anderson, K.; Shofer, J.; Millard, S.; Matsumoto, A.M. Testosterone treatment of men with mild cognitive impairment and low testosterone levels. Am. J. Alzheimers Dis. Other Demen., 2015, 30(4), 421-430.
Wahjoepramono, E.J.; Asih, P.R.; Aniwiyanti, V.; Taddei, K.; Dhaliwal, S.S.; Fuller, S.J.; Foster, J.; Carruthers, M.; Verdile, G.; Sohrabi, H.R.; Martins, R.N. The effects of testosterone supplementation on cognitive functioning in older men. CNS Neurol. Disord. Drug Targets, 2016, 15(3), 337-343.
Hampson, E. Endocrine contributions to sex differences in visuospatial perception and cognition.In: Sex differences in the brain: From genes to behavior; Becker, J.B.; Berkley, K.J.; Geary, N.; Hampson, E.; Herman, J.; Young, E., Eds.; Oxford University Press: New York, 2007, pp. 311-325.
Quaiser-Pohl, C.; Jansen, P.; Lehmann, J.; Kudielka, B.M. Is there a relationship between the performance in a chronometric mental-rotations test and salivary testosterone and estradiol levels in children aged 9-14 years? Dev. Psychobiol., 2016, 58(1), 120-128.
Ostatnikova, D.; Dohnanyiova, M.; Mataseje, A.; Putz, Z.; Laznibatova, J.; Hajek, J. Salivary testosterone and cognitive ability in children. Bratisl. Lek Listy, 2000, 101(8), 470-473. [Slovak.].
Ostatnikova, D.; Celec, P.; Putz, Z.; Hodosy, J.; Schmidt, F.; Laznibatova, J.; Kudela, M. Intelligence and salivary testosterone levels in prepubertal children. Neuropsychologia, 2007, 45(7), 1378-1385.
Celec, P.; Tretinarova, D.; Minarik, G.; Ficek, A.; Szemes, T.; Lakatosova, S.; Schmidtova, E.; Turňa, J.; Kádaši, Ľ.; Ostatnikova, D. Genetic polymorphisms related to testosterone metabolism in intellectually gifted boys. PLoS One, 2013, 8(1)e54751
Shores, M.M.; Moceri, V.M.; Sloan, K.L.; Matsumoto, A.M.; Kivlahan, D.R. Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J. Clin. Psychiatry, 2005, 66(1), 7-14.
McIntyre, R.S.; Mancini, D.; Eisfeld, B.S.; Soczynska, J.K.; Grupp, L.; Konarski, J.Z.; Kennedy, S.H. Calculated bioavailable testosterone levels and depression in middle-aged men. Psychoneuroendocrinology, 2006, 31(9), 1029-1035.
Aydogan, U.; Aydogdu, A.; Akbulut, H.; Sonmez, A.; Yuksel, S.; Basaran, Y.; Uzun, O.; Bolu, E.; Saglam, K. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr. J., 2012, 59(12), 1099-1105.
Ji, E.; Weickert, C.S.; Lenroot, R.; Catts, S.V.; Vercammen, A.; White, C.; Gur, R.E.; Weickert, T.W. Endogenous testosterone levels are associated with neural activity in men with schizophrenia during facial emotion processing. Behav. Brain Res., 2015, 286, 338-346.
Li, J.; Xiao, W.; Sha, W.; Xian, K.; Tang, X.; Zhang, X. Relationship of serum testosterone levels with cognitive function in chronic antipsychotic-treated male patients with schizophrenia. Asia-Pac. Psychiatry, 2015, 7(3), 323-329.
Moore, L.; Kyaw, M.; Vercammen, A.; Lenroot, R.; Kulkarni, J.; Curtis, J.; O’Donnell, M.; Carr, V.J.; Shannon Weickert, C.; Weickert, T.W. Serum testosterone levels are related to cognitive function in men with schizophrenia. Psychoneuroendocrinology, 2013, 38(9), 1717-1728.
Sisek-Šprem, M.; Križaj, A.; Jukić, V.; Milošević, M.; Petrović, Z.; Herceg, M. Testosterone levels and clinical features of schizophrenia with emphasis on negative symptoms and aggression. Nord. J. Psychiatry, 2015, 69(2), 102-109.
Paipa, N.; Stephan-Otto, C.; Cuevas-Esteban, J.; Núñez-Navarro, A.; Usall, J.; Brébion, G. Second-to-fourth digit length ratio is associated with negative and affective symptoms in schizophrenia patients. Schizophr. Res., 2018, 199, 297-303.
Misiak, B.; Frydecka, D.; Loska, O.; Moustafa, A.A.; Samochowiec, J.; Kasznia, J.; Stańczykiewicz, B. Testosterone, DHEA and DHEA-S in patients with schizophrenia: A systematic review and meta-analysis. Psychoneuroendocrinology, 2018, 89, 92-102.
Fuller, P.J.; Lim-Tio, S.S.; Brennan, F.E. Specificity in mineralocorticoid versus glucocorticoid action. Kidney Int., 2000, 57(4), 1256-1264.
Taddei, S.; Virdis, A.; Mattei, P.; Salvetti, A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension, 1993, 21(6 Pt2), 929-933.
Golembiewska, E.; Machowska, A.; Stenvinkel, P.; Lindholm, B. Prognostic value of copeptin in chronic kidney disease: from general population to end-stage renal disease. Curr. Protein Pept. Sci., 2017, 18(12), 1232-1243.
DiBona, G.F. Central angiotensin modulation of baroreflex control of renal sympathetic nerve activity in the rat: Influence of dietary sodium. Acta Physiol. Scand., 2003, 177(3), 285-289.
El Ghorayeb, N.; Bourdeau, I.; Lacroix, A. Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism. Front. Endocrinol., 2016, 7, 72.
Murck, H.; Büttner, M.; Kircher, T.; Konrad, C. Genetic, molecular and clinical determinants for the involvement of aldosterone and its receptors in major depression. Nephron, Physiol., 2014, 128(1-2), 17-25.
Korte, S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci. Biobehav. Rev., 2001, 25(2), 117-142.
Jezova, D. Control of ACTH secretion by excitatory amino acids: Functional significance and clinical implications. Endocrine, 2005, 28(3), 287-294.
Stier, C.T., Jr; Serova, L.I.; Singh, G.; Sabban, E.L. Stress triggered rise in plasma aldosterone is lessened by chronic nicotine infusion. Eur. J. Pharmacol., 2004, 495(2-3), 167-170.
Moncek, F.; Aguilera, G.; Jezova, D. Insufficient activation of adrenocortical but not adrenomedullary hormones during stress in rats subjected to repeated immune challenge. J. Neuroimmunol., 2003, 142(1-2), 86-92.
Kajihara, H.; Malliwah, J.A.; Matsumura, M.; Taguchi, K.; Iijima, S. Changes in blood cortisol and aldosterone levels and ultrastructure of the adrenal cortex during hemorrhagic shock. Pathol. Res. Pract., 1983, 176(2-4), 324-340.
Belyakova, E.I.; Mendzheritskii, A.M. Adrenocortical and thyroid systems of rats during the initial period of nociceptive influences. Neurosci. Behav. Physiol., 2006, 36(5), 561-564.
Varga, J.; Ferenczi, S.; Kovács, K.J.; Garafova, A.; Jezova, D.; Zelena, D. Comparison of stress-induced changes in adults and pups: Is aldosterone the main adrenocortical stress hormone during the perinatal period in rats? PLoS One, 2013, 8(9)e72313
Csanova, A.; Hlavacova, N.; Hasiec, M.; Pokusa, M.; Prokopova, B.; Jezova, D. β(3)-Adrenergic receptors, adipokines and neuroendocrine activation during stress induced by repeated immune challenge in male and female rats. Stress, 2017, 20(3), 294-302.
Kubzansky, L.D.; Adler, G.K. Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease. Neurosci. Biobehav. Rev., 2010, 34(1), 80-86.
Makatsori, A.; Duncko, R.; Moncek, F.; Loder, I.; Katina, S.; Jezova, D. Modulation of neuroendocrine response and non-verbal behavior during psychosocial stress in healthy volunteers by the glutamate release-inhibiting drug lamotrigine. Neuroendocrinology, 2004, 79(1), 34-42.
Bae, Y.J.; Reinelt, J.; Netto, J.; Uhlig, M.; Willenberg, A.; Ceglarek, U.; Villringer, T.J.; Gaebler, M.; Kratzsch, J. Salivary cortisone, as a biomarker for psychosocial stress, is associated with state anxiety and heart rate. Psychoneuroendocrinology, 2018, 101, 35-41.
Hlavacova, N.; Solarikova, P.; Marko, M.; Brezina, I.; Jezova, D. Blunted cortisol response to psychosocial stress in atopic patients is associated with decrease in salivary alpha-amylase and aldosterone: Focus on sex and menstrual cycle phase. Psychoneuroendocrinology, 2017, 78, 31-38.
Hlavacova, N.; Wes, P.D.; Ondrejcakova, M.; Flynn, M.E.; Poundstone, P.K.; Babic, S.; Murck, H.; Jezova, D. Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. Int. J. Neuropsychopharmacol., 2012, 15(2), 247-265.
Aguilera, G.; Kiss, A.; Luo, X.; Akbasak, B.S. The renin angiotensin system and the stress response. Ann. N. Y. Acad. Sci., 1995, 771, 173-186.
Grippo, A.J.; Johnson, A.K. Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress, 2009, 12(1), 1-21.
Schiffrin, E.L. Effects of aldosterone on the vasculature. Hypertension, 2006, 47(3), 312-318.
Garg, R.; Adler, G.K. Aldosterone and the mineralocorticoid receptor: Risk factors for cardiometabolic disorders. Curr. Hypertens. Rep., 2015, 17(7), 52.
Gilbert, K.C.; Brown, N.J. Aldosterone and inflammation. Curr. Opin. Endocrinol. Diabetes Obes., 2010, 17(3), 199-204.
Bruder-Nascimento, T.; da Silva, M.A.; Tostes, R.C. The involvement of aldosterone on vascular insulin resistance: Implications in obesity and type 2 diabetes. Diabetol. Metab. Syndr., 2014, 6(1), 90.
Geerling, J.C.; Loewy, A.D. Aldosterone in the brain. Am. J. Physiol. Renal Physiol., 2009, 297(3), F559-F576.
Huang, B.S.; Leenen, F.H. Mineralocorticoid actions in the brain and hypertension. Curr. Hypertens. Rep., 2011, 13(3), 214-220.
Hlavacova, N.; Jezova, D. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm. Behav., 2008, 54, 90-97.
Franklin, M.; Hlavacova, N.; Babic, S.; Pokusa, M.; Bermudez, I.; Jezova, D. Aldosterone signals the onset of depressive behaviour in a female rat model of depression along with SSRI treatment resistance. Neuroendocrinology, 2015, 102(4), 274-287.
Sonino, N.; Fallo, F.; Fava, G.A. Psychological aspects of primary aldosteronism. Psychother. Psychosom., 2006, 75, 327-330.
Künzel, H.E. Psychopathological symptoms in patients with primary hyperaldosteronism--possible pathways. Horm. Metab. Res., 2012, 44(3), 202-207.
Apostolopoulou, K.; Künzel, H.E.; Gerum, S.; Merkle, K.; Schulz, S.; Fischer, E.; Pallauf, A.; Brand, V.; Bidlingmaier, M.; Endres, S.; Beuschlein, F.; Reincke, M. Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study. World J. Biol. Psychiatry, 2014, 15(1), 26-35.
Murck, H.; Held, K.; Ziegenbein, M.; Künzel, H.; Koch, K.; Steiger, A. The renin-angiotensin-aldosterone system in patients with depression compared to controls-a sleep endocrine study. BMC Psychiatry, 2003, 3, 15.
Emanuele, E.; Geroldi, D.; Minoretti, P.; Coen, E.; Politi, P. Increased plasma aldosterone in patients with clinical depression. Arch. Med. Res., 2005, 36, 544-548.
Häfner, S.; Baumert, J.; Emeny, R.T.; Lacruz, M.E.; Bidlingmaier, M.; Reincke, M.; Kuenzel, H.; Holle, R.; Rupprecht, R.; Ladwig, K.H. To live alone and to be depressed, an alarming combination for the renin-angiotensin-aldosterone-system (RAAS). Psychoneuroendocrinology, 2012, 37, 230-237.
Häfner, S.; Baumert, J.; Emeny, R.T.; Lacruz, M.E.; Bidlingmaier, M.; Reincke, M.; Ladwig, K.H. Hypertension and depressed symptomatology: A cluster related to the activation of the renin-angiotensin-aldosterone system (RAAS). Findings from population based KORA F4 study. Psychoneuroendocrinology, 2013, 38, 2065-2074.
Segeda, V.; Izakova, L.; Hlavacova, N.; Bednarova, A.; Jezova, D. Aldosterone concentrations in saliva reflect the duration and severity of depressive episode in a sex dependent manner. J. Psychiatr. Res., 2017, 91, 164-168.
Connell, J.M.; Davies, E. The new biology of aldosterone. J. Endocrinol., 2005, 186(1), 1-20.
Haseroth, K.; Christ, M.; Falkenstein, E.; Wehling, M. Aldosterone- and progesterone-membrane-binding proteins: New concepts of nongenomic steroid action. Curr. Protein Pept. Sci., 2000, 1(4), 385-401.
Fischer, A.K.; von Rosenstiel, P.; Fuchs, E.; Goula, D.; Almeida, O.F.; Czéh, B. The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat. Brain Res., 2002, 947(2), 290-293.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Published on: 23 October, 2019
Page: [1112 - 1118]
Pages: 7
DOI: 10.2174/1389203720666190704151254
Price: $65

Article Metrics

PDF: 24
PRC: 1